BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17399779)

  • 1. Eosinophilic disorders.
    Simon D; Simon HU
    J Allergy Clin Immunol; 2007 Jun; 119(6):1291-300; quiz 1301-2. PubMed ID: 17399779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy.
    Gotlib J; Cross NC; Gilliland DG
    Best Pract Res Clin Haematol; 2006; 19(3):535-69. PubMed ID: 16781488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome.
    Bain BJ
    Br J Haematol; 1996 Oct; 95(1):2-9. PubMed ID: 8857931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T lymphocyte control of human eosinophilic granulopoiesis. Clonal analysis in an idiopathic hypereosinophilic syndrome.
    Raghavachar A; Fleischer S; Frickhofen N; Heimpel H; Fleischer B
    J Immunol; 1987 Dec; 139(11):3753-8. PubMed ID: 3500229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders.
    Valent P
    Blood Rev; 2009 Jul; 23(4):157-65. PubMed ID: 19246139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700.
    Kim YJ; Prussin C; Martin B; Law MA; Haverty TP; Nutman TB; Klion AD
    J Allergy Clin Immunol; 2004 Dec; 114(6):1449-55. PubMed ID: 15577851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilic myeloid disorders.
    Noel P
    Semin Hematol; 2012 Apr; 49(2):120-7. PubMed ID: 22449622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophilia-associated muscle disorders: an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms.
    Cantarini L; Volpi N; Carbotti P; Greco G; Aglianò M; Bellisai F; Giannini F; Alessandrini C; Grasso G; Galeazzi M
    J Clin Pathol; 2009 May; 62(5):442-7. PubMed ID: 19139036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypereosinophilia of the blood. II. Classification. Benign essential hypereosinophilia. Eosinophilia caused by systemic eosinophilic hemopathies].
    Lovisetto P; Manachino D; Biarese V; Marchi L; Andrione P
    Minerva Med; 1985 May; 76(22-23):1049-53. PubMed ID: 4011004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of eosinophilic gastrointestinal diseases.
    Mueller S
    Best Pract Res Clin Gastroenterol; 2008; 22(3):425-40. PubMed ID: 18492564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypereosinophilic syndromes.
    Roufosse FE; Goldman M; Cogan E
    Orphanet J Rare Dis; 2007 Sep; 2():37. PubMed ID: 17848188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management.
    Gotlib J
    Am J Hematol; 2012 Sep; 87(9):903-14. PubMed ID: 22926771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies and open questions in the definitions and classification of the hypereosinophilic syndromes and eosinophilic leukemias.
    Valent P; Horny HP; Bochner BS; Haferlach T; Reiter A
    Semin Hematol; 2012 Apr; 49(2):171-81. PubMed ID: 22449627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma eosinophil cationic protein, interleukin-5, and ECP/Eo count ratio in patients with various eosinophilic diseases.
    Park YJ; Oh EJ; Park JW; Kim M; Han K
    Ann Clin Lab Sci; 2006; 36(3):262-6. PubMed ID: 16951266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease.
    Bhattacharya B; Carlsten J; Sabo E; Kethu S; Meitner P; Tavares R; Jakate S; Mangray S; Aswad B; Resnick MB
    Hum Pathol; 2007 Dec; 38(12):1744-53. PubMed ID: 17900656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Incidence and differential diagnosis of chronic eosinophilic leukemia].
    Büsche G; Nolte M; Schlue J; Kreft A; Kreipe HH
    Pathologe; 2002 Nov; 23(6):419-25. PubMed ID: 12436294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Practical approach to hypereosinophilia].
    Roufosse F; Cogan E
    Rev Med Brux; 2008 Sep; 29(4):400-8. PubMed ID: 18949995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignancy: Case Report: Hypereosinophilia Progressing to Granulocytic Sarcoma and Acute Myelocytic Leukemia with Trisomy 8: A Case Report and Review of the Literature.
    Lynott A; Ravandi-Kashani F; Giles FJ
    Hematology; 2000; 4(6):487-493. PubMed ID: 11399591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic disorders in various diseases.
    Celestin J; Frieri M
    Curr Allergy Asthma Rep; 2012 Feb; 12(1):18-24. PubMed ID: 22160831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.